REQUEST A DEMO
Total
USD $0.00
Search more companies

Imuna Pharm, a.s. (Slovakia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Imuna Pharm, a.s. Profile Updated: September 20, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2020 Available in: English Download a sample report

On January 1st, 1953 a company Imuna was established as a state enterprise in Sarisske Michalany. Later IMUNA PHARM, a. s. took over portfolio of the original company IMUNA and continues in production of the mentioned assortment of pharmaceutical products for the health service. Currently, the company provides the collection of plasma in the Slovak Republic, and its subsequent transfer to the Spain firm Grifols, where is treated and then returned to the Slovak market in the form of products. The company has purchased shares of the Czech pharmaceutical company SEVAPHARMA, a. s., in 2005, and whereby its portfolio was extended by the vaccine, allergen and immunomodulator production. IMUNA PHARM, a. s. is aimed at research and development activities as well.

Headquarters
Jarkova 269/17
Sarisske Michalany; Presovsky; Postal Code: 08222

Contact Details: Purchase the Imuna Pharm, a.s. report to view the information.

Website: http://www.imuna.sk

Basic Information
Total Employees:
Purchase the Imuna Pharm, a.s. report to view the information.
Outstanding Shares:
Purchase the Imuna Pharm, a.s. report to view the information.
Registered Capital:
Purchase the Imuna Pharm, a.s. report to view the information.
Ratings:
Purchase the Imuna Pharm, a.s. report to view the information.
Incorporation Date:
June 26, 2001
Key Executives
Purchase this report to view the information.
Chairman of the Board
Purchase this report to view the information.
Member of the Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Ownership Details
Subsidiaries
Company Performance
Financial values in the chart are available after Imuna Pharm, a.s. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-24.82%
Total operating revenue
-19.15%
Operating profit (EBIT)
-536.12%
EBITDA
-43.28%
Net Profit (Loss) for the Period
-158.67%
Total assets
-6.37%
Total equity
-18.2%
Operating Profit Margin (ROS)
-7.86%
Net Profit Margin
-8.64%
Return on Equity (ROE)
-15.21%
Debt to Equity Ratio
25.27%
Quick Ratio
-0.13%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?